The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Aronex Pharmaceuticals, Inc.

Aronex Pharmaceuticals, Inc.
Nasdaq: ARNX
Change
symbol:
     
 NEWS FROM THE WIRES
Genzyme Transgenics names new chairman and CEO
Jul 19 2001 05:23 AM PDT

More WIRE STORIES about this company

 PROFILE
Development-stage Aronex Pharmaceuticals targets cancer and infectious diseases with four products originally licensed from the University of Texas M.D. Anderson Cancer Center. Nyotran may fight such infectious diseases as fungal infections and meningitis; partner Abbott Laboratories is helping develop the drug. Aronex is also developing Annamycin, which may treat breast cancer and leukemia, and Aroplatin, a potential treatment for lung cancer and renal cell carcinoma. It received a letter of non-approval from the FDA for lead drug candidate ATRAGEN, which Aronex was developing to battle acute promyelocytic leukemia; the firm cut its staff in response. Immunotherapy developer Antigenics is set to buy the firm.

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 3.20
1-Yr. Sales Growth: (71.2)%
Employees: 29
Revenue per employee: $110,344.83

 KEY PEOPLE
• Geoffrey F. Cox
    CEO
• Terance A. Murnane
    CFO

 CONTACT INFO
8707 Technology Forest Place
The Woodlands, TX 77381
US
Phone: 281-367-1666
Fax: 281-367-1676
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001